results from the himalaya clinical trial for hepatocellular carcinoma
Published 1 month ago • 163 plays • Length 7:07Download video MP4
Download video MP3
Similar videos
-
3:35
asco 2020: himalaya trial for advanced hcc
-
7:48
himalaya: study of tremelimumab and durvalumab as first-line therapy in patients with uhcc
-
4:56
himalaya: tremelimumab durvalumab in unresectable hcc
-
3:34
himalaya: does underlying liver function impact efficacy of tremelimumab plus durvalumab for hcc?
-
4:03
results of phase ii trial comparing tace and sbrt for hepatocellular carcinoma
-
1:26:24
hepatocellular carcinoma: expert insights from the patient casebook
-
4:56
himalaya: tremelimumab durvalumab in unresectable hcc
-
13:04
4 groundbreaking advances in liver cancer treatment
-
15:03
survival & cost-effectiveness & impact of positive clinical trials in the management of hcc in asia
-
53:05
update in the clinical management of hepatocellular carcinoma
-
27:46
update on screening for hepatocellular carcinoma (hcc)
-
34:29
management of hepatocellular carcinoma before transplant
-
35:53
update on initial management of advanced hcc
-
55:23
hepatocellular carcinoma: a guide to integrating emerging therapies into current treatment paradigms
-
37:54
easl studio - special edition - live from the liver cancer summit 2022
-
3:49
update from esmo 2024: immunotherapy (io) for hcc
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
1:17:43
hepatocellular carcinoma: examining scientific data and evidence with your multidisciplinary team
-
7:15
checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma